HomeDCPXF • OTCMKTS
add
DanCann Pharma A/S
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 244.00K | -65.24% |
Operating expense | 1.80M | -5.11% |
Net income | -2.93M | 12.99% |
Net profit margin | -1.20K | -150.34% |
Earnings per share | — | — |
EBITDA | -2.33M | 3.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 828.00K | 1,480.00% |
Total assets | 14.62M | -3.62% |
Total liabilities | 2.37M | -68.59% |
Total equity | 12.25M | — |
Shares outstanding | 3.99M | — |
Price to book | 0.00 | — |
Return on assets | -45.15% | — |
Return on capital | -52.58% | — |
Cash Flow
Net change in cash
| (DKK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.93M | 12.99% |
Cash from operations | -2.64M | -104.96% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -2.64M | -152.77% |
Free cash flow | -1.58M | -163.65% |
About
Founded
2018
Website
Employees
5
